ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming
Yann Grobs(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Nicolas Flamand(Natural Sciences and Engineering Research Council of Canada), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Elizabeth Dumais(Lung Institute), Charlotte Romanet(Canadian Heart Research Centre), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), Olivier Boucherat, Pierre Voisine(Lung Institute), Manon Mougin(Canadian Heart Research Centre), Reem El Kabbout(Canadian Heart Research Centre), Charlie Théberge(Canadian Heart Research Centre), Jean Perron(Université du Québec à Chicoutimi), François Potus(Queen's University), Alice Bourgeois, Sandra Martineau(Canadian Heart Research Centre)
Cited by 1
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|687
The CB2 receptor and its role as a regulator of inflammation
|Cellular and Molecular Life Sciences|2016|579
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
|Frontiers in Pharmacology|2022|187
Surgical Explantation After TAVR Failure
|JACC: Cardiovascular Interventions|2021|157